Back to User profile » Dr Yafeng Wang

Papers published by Dr Yafeng Wang:


Relationship of PPARG, PPARGC1A, and PPARGC1B polymorphisms with susceptibility to hepatocellular carcinoma in an eastern Chinese Han population

Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Chen Y, Liu L

OncoTargets and Therapy 2018, 11:4651-4660

Published Date: 8 August 2018

CTLA4 tagging polymorphisms and risk of colorectal cancer: a case–control study involving 2,306 subjects

Zou C, Qiu H, Tang W, Wang Y, Lan B, Chen Y

OncoTargets and Therapy 2018, 11:4609-4619

Published Date: 7 August 2018

miRNA-146a rs2910164 C>G polymorphism increased the risk of esophagogastric junction adenocarcinoma: a case–control study involving 2,740 participants

Chen Y, Tang W, Liu C, Lin J, Wang Y, Zhang S, Chen G, Zheng X

Cancer Management and Research 2018, 10:1657-1664

Published Date: 25 June 2018

Investigation of LEP and LEPR polymorphisms with the risk of hepatocellular carcinoma: a case–control study in Eastern Chinese Han population

Zhang S, Jiang J, Chen Z, Wang Y, Tang W, Liu C, Liu L, Chen Y

OncoTargets and Therapy 2018, 11:2083-2089

Published Date: 11 April 2018

The relationship between IGF2BP2 and PPARG polymorphisms and susceptibility to esophageal squamous-cell carcinomas in the eastern Chinese Han population

Qiu H, Wang Y, Kang M, Ding H, Liu C, Tang W, Xiao Z, Chen Y

OncoTargets and Therapy 2017, 10:5525-5532

Published Date: 21 November 2017

Investigation of cyclin D1 rs9344 G>A polymorphism in colorectal cancer: a meta-analysis involving 13,642 subjects

Qiu H, Cheng C, Wang Y, Kang M, Tang W, Chen S, Gu H, Liu C, Chen Y

OncoTargets and Therapy 2016, 9:6641-6650

Published Date: 27 October 2016